D.E. Shaw & Co
CYNA

D.E. Shaw & Co’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

D.E. Shaw & Co’s Portfolio CYNA Stock Details CYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-13,511
Closed -$209K – 4015
2015
Q4 		$209K Buy
+13,511
New +$205K ﹤0.01% 3541

Other funds holding CYNA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

D.E. Shaw & Co's CYNA Position: Q1 2016 in Review

D.E. Shaw & Co sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q1 2016, closing a stake of 13,511 shares — an estimated $209K sold.

D.E. Shaw & Co first reported a position in CYNA in Q4 2015 and held it in 1 quarter. The position peaked at $209K in Q4 2015. 31 funds tracked by Wall St. Rank hold CYNA as of Q1 2016.

  • D.E. Shaw & Co reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q1 2016 after selling out during the quarter.
  • D.E. Shaw & Co sold 13,511 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q1 2016, an estimated $209K.
  • D.E. Shaw & Co first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q4 2015 and held it in 1 quarter.
  • D.E. Shaw & Co's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $209K in Q4 2015.
  • 31 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q1 2016.

Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.